Literature DB >> 9558403

Reduced ex vivo interleukin-8 production by neutrophils in septic and nonseptic systemic inflammatory response syndrome.

C Marie1, J Muret, C Fitting, M R Losser, D Payen, J M Cavaillon.   

Abstract

Ex vivo cytokine production by circulating lymphocytes and monocytes is reduced in patients with infectious or noninfectious systemic inflammatory response syndrome. Very few studies have addressed the reactivity of polymorphonuclear cells (PMN). To analyze further the relative contribution of systemic inflammatory response syndrome alone or in combination with infection we studied the interleukin-8 (IL-8) production by PMN isolated from patients who had undergone cardiac surgery with cardiopulmonary bypass (CPB) and patients with sepsis. Cells were activated with either lipopolysaccharide (LPS) or heat-killed streptococci. Compared with healthy controls, the release of IL-8 by PMN in both groups of patients was significantly reduced whether activated by LPS, independently of its concentration and origin, or by heat-killed streptococci. These observations suggest that stressful conditions related to inflammation, independently of infection, rapidly dampened the reactivity of circulating PMN. We investigated whether the observed diminished reactivity of PMN might reflect an endotoxin tolerance phenomenon. Our in vitro experiments with PMN from healthy controls indicated that PMN could not be rendered tolerant stricto sensu. However, our data suggested that LPS-induced mediators such as IL-10 may be responsible for the observed anergy in patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9558403

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  [Clinical course and prognostic significance of immunological and functional parameters after severe trauma].

Authors:  S Lendemans; E Kreuzfelder; C Waydhas; D Nast-Kolb; S Flohé
Journal:  Unfallchirurg       Date:  2004-03       Impact factor: 1.000

2.  Factors prolonging length of stay in the cardiac intensive care unit following the arterial switch operation.

Authors:  Derek S Wheeler; Catherine L Dent; Peter B Manning; David P Nelson
Journal:  Cardiol Young       Date:  2007-12-20       Impact factor: 1.093

3.  Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M.

Authors:  Jane C Deng; Genhong Cheng; Michael W Newstead; Xianying Zeng; Koichi Kobayashi; Richard A Flavell; Theodore J Standiford
Journal:  J Clin Invest       Date:  2006-08-17       Impact factor: 14.808

Review 4.  Endotoxemia-menace, marker, or mistake?

Authors:  Robert S Munford
Journal:  J Leukoc Biol       Date:  2016-07-14       Impact factor: 4.962

5.  Induction of cell-associated chemokines after endotoxin administration to healthy humans.

Authors:  D P Olszyna; E De Jonge; P E Dekkers; S J van Deventer; T van der Poll
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

6.  Reduced Th1, but not Th2, cytokine production by lymphocytes after in vivo exposure of healthy subjects to endotoxin.

Authors:  F N Lauw; T ten Hove; P E Dekkers; E de Jonge; S J van Deventer; T van Der Poll
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

7.  Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection.

Authors:  N Rayhane; C Fitting; O Lortholary; F Dromer; J M Cavaillon
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

8.  CpG-ODN and MPLA prevent mortality in a murine model of post-hemorrhage-Staphyloccocus aureus pneumonia.

Authors:  Antoine Roquilly; Laetitia Gautreau; Jean Pierre Segain; Pierre de Coppet; Véronique Sebille; Cédric Jacqueline; Jocelyne Caillon; Gilles Potel; Corinne Lejus; Régis Josien; Karim Asehnoune
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

9.  Treatment with an anti-CD14 monoclonal antibody delays and inhibits lipopolysaccharide-induced gene expression in humans in vivo.

Authors:  C Arnold Spek; Annelies Verbon; Hella Aberson; John P Pribble; Cathal J McElgunn; Terence Turner; Tim Axtelle; Jan Schouten; Tom Van Der Poll; Pieter H Reitsma
Journal:  J Clin Immunol       Date:  2003-03       Impact factor: 8.317

10.  Immune monitoring of patients with septic shock by measurement of intraleukocyte cytokines.

Authors:  Thierry Fumeaux; Julien Dufour; Sabine Stern; Jérôme Pugin
Journal:  Intensive Care Med       Date:  2004-09-11       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.